The objective of the present investigation was to formulate and evaluate hydrodynamically balanced floating matrix controlled drug delivery system of diltiazem hydrochloride. Floating matrix tablets are associated with advantages of increased bioavailability and minimizing the dosing frequency. Diltiazem hydrochloride is a calcium channel blocker, an anti-hypertensive and anti-anginal drug, which undergoes extensive firstpass metabolism and display poor bioavailability. It has an elimination half-life of 3 to 4.5 h and an absorption zone from the upper intestinal tract. Gastric floating of diltiazem hydrochloride tablets results from effervescence produced by the reaction between sodium bicarbonate and hydrochloric acid in stomach. Seven formulations of floating tablets were prepared using direct compression technique with low viscosity polymer such as HPMC K100LV, high viscosity polymers such as HPMC K4M, K15M, and carbopol in different ratios. The evaluation results revealed that all formulations comply with the specification of official pharmacopoeias and/or standard reference with respect to general appearance, content uniformity, hardness, friability and buoyancy. Accelerated stability studies carried out at different temperatures, 27 ± 2 °C, 40 ± 2 °C and 7 ± 2 °C did show no changes in physicochemical properties at the end of 8 weeks indicating all the formulations are stable. Out of all the formulation developed, formulation F containing equal ratio of HPMC K4M and K100LV showed optimum floating time and in vitro drug 6 release of 82.19% at the end of 8 h. Thus it is summarized; high viscosity grade polymer HPMC K4M, low viscosity grade polymer HPMC K100LV and carbopol can be successfully used in formulation of sustained release gastro retentive floating drug delivery system.
Introduction
The oral drug delivery is by far the most preferable route of drug delivery system, due to ease of administration, Where, θ = angle of repose, h = height, r = radius.
Materials and Methods

Diltiazem
(b) Bulk Density
The bulk density of a powder is dependent on particle packing and changes as the powder consolidates. A consolidated powder is likely to have a greater arch strength than a less consolidated one and therefore more resistant to powder flow. The ease with which a
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powder consolidates can be used as an indirect method of quantifying powder. Apparent bulk density (g/ml) was determined by pouring preserved bulk powder into a graduated cylinder via a large funnel and measuring the
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volume and weight . Bulk density can then be calculated by the following formula.
Bulk density = W/Vo
Where, W = wt. of powder, V = initial volume.
(c) Tapped Density
A quantity of 2 gm of powder blend from each formula, previously shaken to break any agglomerates formed, was introduced in to 10 ml measuring cylinder. After that the initial volume was noted and the cylinder was allowed to fall under its own weight on to a hard surface from the height of 2.5 cm at second intervals. Tapping was continued until no further change in volume was
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noted . Tapered density was calculated using the following equations.
Tapped density = W/V f
Where, W = wt. of powder, V = final volume. to withstand mechanical shocks while handling .
(c) Friability Test
The friability of tablets was determined using Roche 
(d) Weight Variation Test
Twenty tablets were selected randomly from each batch and weighed individually using electronic balance 1 6 , 1 7
(Ohause) to check for weight variation .
Pharmacopoeial parameters are displayed in Table 2 . 
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The solution was filtered through Whattman filter paper.
1 ml of the above solution was transferred to a 100 ml volumetric flask and diluted to 100 ml with 0.1 N HCl and the absorbance was measured at 236 nm using UV / visible spectrophotometer (Shimadzu UV -1600/1700).
The percentage of diltiazem hydrochloride was 9,10 determined using calibration curve .
(f) In Vitro Buoyancy Test
The prepared tablets were subjected to in vitro buoyancy test by placing them in 250 ml beaker containing 200 ml 
(g) In Vitro Dissolution Studies
The dissolution study was carried out using USP II (paddle method) apparatus in 900 ml of 0.1 N HCl (pH 1.2) for 12
h. The temperature of the dissolution medium was kept at 37± 0.5 ºC and the paddle was set at 100 rpm. 10 ml of sample solution was withdrawn at specified interval of time and filtered through Whattman filter paper. The sample was replaced with fresh dissolution medium.
The sample diluted to a suitable concentration with 0.1 N HCL. The absorbance of the withdrawn samples was measured at λ 236 nm using a Shimadzu UVmax 11, 13, 20 1600/1700 series spectrophotometer .
(h) Stability Studies
The stability studies of all the formulations were studied at different temperatures using the reported standard procedure. The tablets were wrapped in aluminum foil and placed in Petri dishes. These containers were stored at ambient humid conditions, at room temperature (27 ± 
II. Post-Compression Parameters
Tablet Dimensions
Thickness and diameter of the seven formulations did not exceed the limit of ± 5% of the determined standard value; hence all the formulations comply with the proposed limits of pharmacopoeia. The values are shown in the tablets 4.
Hardness Test
The measured hardness of tablets of each batch ranged 2 between 6.5 to 7.3 kg/cm as reported in Table 4 . This ensures good handling characteristics of all batches.
Friability Test
The % friability was found to be in the range 0.52% to 0.80% ensuring that the tablets are mechanically stable.
The values of friability test are tabulated in Table 4 .
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All the formulated tablets comply with the weight variation limits of the Indian Pharmacopoeia as the values are in the range of 1.5% to 3% as displayed in Table   4 .
Drug Content Estimation
The percentage of drug content for F to F was found to 1 7 be in the range of 97.82% to 99.41%, as tabulated in Table   4 , of diltiazem hydrochloride, it complies with official specifications.
In Vitro Buoyancy Test
In Vitro buoyancy test was performed on all the batches (F to F ). On immersion in 0.1N HCL solution pH (1.2) at 1 7 37 °C, the tablets floated, and remained buoyant without disintegration. Table 5 shows the results of in vitro buoyancy study from the results it can be concluded that the batch containing high viscosity grade HPMC K4M or HPMC K15M polymer and carbopol i.e. formulations F , 1 F and F showed good buoyancy, total floating time of 4 6 more than 8 h, whereas formulation F containing low 
In Vitro Dissolution Studies
In vitro dissolution studies showed highest drug release of 82.19% from the formulation F followed by F , F , F , F , 
Conclusion
The pre-compression evaluation parameters concludes 10 10 More than 60 mg but less than 250 mg 7.5 7.5 250 mg or more 5 5 l Since, the average weight of the tablets is 250 mg; the percentage deviation is taken as ± 5 
